{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "26330666",
  "DateCompleted": {
    "Year": "2016",
    "Month": "06",
    "Day": "07"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "11",
    "Day": "11"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0065-7778",
      "JournalIssue": {
        "Volume": "126",
        "PubDate": {
          "Year": "2015"
        }
      },
      "Title": "Transactions of the American Clinical and Climatological Association",
      "ISOAbbreviation": "Trans Am Clin Climatol Assoc"
    },
    "ArticleTitle": "Gordon Wilson Lecture: Infectious Disease Causes of Cancer: Opportunities for Prevention and Treatment.",
    "Pagination": {
      "StartPage": "117",
      "EndPage": "132",
      "MedlinePgn": "117-32"
    },
    "Abstract": {
      "AbstractText": [
        "The role of infectious agents in cancer is generally underappreciated. However, approximately 20% of human cancers are caused by infectious agents and as such they rank second only to tobacco as a potentially preventable cause in humans. Specific viruses, parasites, and bacteria have been linked to specific human cancers. The infectious etiology for these specific cancers provides opportunities for prevention and treatment."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Boston, Massachusetts."
          }
        ],
        "LastName": "Howley",
        "ForeName": "Peter M",
        "Initials": "PM"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Lecture"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Trans Am Clin Climatol Assoc",
    "NlmUniqueID": "7507559",
    "ISSNLinking": "0065-7778"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Infective Agents"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Infective Agents"
    },
    {
      "QualifierName": [
        "drug effects",
        "pathogenicity"
      ],
      "DescriptorName": "Bacteria"
    },
    {
      "QualifierName": [
        "complications",
        "diagnosis",
        "microbiology",
        "therapy"
      ],
      "DescriptorName": "Bacterial Infections"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cell Transformation, Viral"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Host-Pathogen Interactions"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "diagnosis",
        "etiology",
        "prevention & control"
      ],
      "DescriptorName": "Neoplasms"
    },
    {
      "QualifierName": [
        "drug effects",
        "pathogenicity"
      ],
      "DescriptorName": "Parasites"
    },
    {
      "QualifierName": [
        "complications",
        "diagnosis",
        "parasitology",
        "therapy"
      ],
      "DescriptorName": "Parasitic Diseases"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Risk Factors"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Treatment Outcome"
    },
    {
      "QualifierName": [
        "complications",
        "diagnosis",
        "therapy",
        "virology"
      ],
      "DescriptorName": "Tumor Virus Infections"
    },
    {
      "QualifierName": [
        "drug effects",
        "pathogenicity"
      ],
      "DescriptorName": "Viruses"
    }
  ],
  "CoiStatement": "Potential Conflicts of Interest: None disclosed."
}